日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Nanoencapsulated Sirolimus Plus Pegadricase (NASP) in Uncontrolled Gout: Current Status and Future Directions

纳米封装西罗莫司联合培加地塞米松酶（NASP）治疗难治性痛风：现状与未来方向

期刊:Drugs
影响因子:14.4
doi:10.1007/s40265-025-02267-w
Baraf, Herbert S B; Schlesinger, Naomi; Strand, Vibeke
痛风
代谢
发表日期：2026
文献求助 收藏

Mining for Mitochondria: 68 Mitogenomes for Wrasses and Parrotfishes (F: Labridae) From Off-Target UCE Data

线粒体挖掘：从非靶标UCE数据中获得68个隆头鱼和鹦嘴鱼（F: Labridae）的线粒体基因组

期刊:Ecology and Evolution
影响因子:2.3
doi:10.1002/ece3.73270
Swami, Aditya V; Baraf, Lauriane M; Cowman, Peter F
线粒体
发表日期：2026
文献求助 收藏

Phylogenomics of Marine Angelfishes: Diagnosing Sources of Systematic Discordance for an Iconic Reef Fish Family (F: Pomacanthidae)

海洋神仙鱼的系统发育基因组学：诊断标志性珊瑚礁鱼类科（F: Pomacanthidae）系统发育不一致的来源

期刊:Systematic Biology
影响因子:5.7
doi:10.1093/sysbio/syaf016
Baraf, Lauriane M; Hung, Julia Y; Cowman, Peter F
Fish
发表日期：2025
文献求助 收藏

Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort

患有朗格汉斯细胞组织细胞增生症和下丘脑-垂体受累的患者：来自 HEROS 研究队列的启示

期刊:Pituitary
影响因子:3.4
doi:10.1007/s11102-025-01576-3
Masri Iraqi, Hiba; Tsoli, Marina; Barbot, Mattia; Colao, Annamaria; Ferone, Diego; Toth, Miklos; Pigarova, Ekaterina; Akirov, Amit; Baraf, Lior; Greenman, Yona; Doknic, Mirjana; Kaltsas, Gregory; Shimon, Ilan
细胞生物学
神经科学
免疫/内分泌
发表日期：2025
文献求助 收藏

Cushing Disease Mimicking Ectopic Adrenocorticotropic Hormone-Secreting Disease

库欣病模拟异位促肾上腺皮质激素分泌疾病

期刊:
影响因子:
doi:10.1016/j.aed.2025.06.001
Fisher, David Louis; Fraenkel, Merav; Baraf, Lior
免疫/内分泌
发表日期：2025
文献求助 收藏

The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout

COMPARE 是一项头对头、随机对照试验，旨在比较 SEL-212（培加替酶联合雷帕霉素纳米颗粒，ImmTOR™）与培洛替酶治疗难治性痛风的疗效。

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/kead333
Baraf, Herbert S B; Khanna, Puja P; Kivitz, Alan J; Strand, Vibeke; Choi, Hyon K; Terkeltaub, Robert; Dalbeth, Nicola; DeHaan, Wesley; Azeem, Rehan; Traber, Peter G; Keenan, Robert T
痛风
mTOR
代谢
OMP
COMP
OMPA
发表日期：2024
文献求助 收藏

Safety of In-hospital Parenteral Antiosteoporosis Therapy Following a Hip Fracture: A Retrospective Cohort

髋部骨折后住院期间肠外抗骨质疏松治疗的安全性：一项回顾性队列研究

期刊:Journal of the Endocrine Society
影响因子:3.1
doi:10.1210/jendso/bvae172
Abu-Jwead, Alaa; Fisher, David L; Goldabart, Adi; Yoel, Uri; Press, Yan; Tsur, Anat; Fraenkel, Merav; Baraf, Lior
代谢
骨折
骨质疏松
发表日期：2024
文献求助 收藏

Comparative mitogenomics of marine angelfishes (F: Pomacanthidae)

海洋神仙鱼（F: Pomacanthidae）的比较线粒体基因组学

期刊:Ecology and Evolution
影响因子:2.3
doi:10.1002/ece3.70127
Baraf, Lauriane M; Hung, Julia Y; Pratchett, Morgan S; Cowman, Peter F
线粒体
发表日期：2024
文献求助 收藏

Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study

Upadacitinib治疗类风湿性关节炎患者的长期疗效和安全性：BALANCE-EXTEND开放标签扩展研究的最终结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00557-x
Kivitz, Alan; Wells, Alvin F; Vargas, Juan I; Baraf, Herbert S B; Rischmueller, Maureen; Klaff, Justin; Khan, Nasser; Li, Yihan; Carter, Kyle; Friedman, Alan; Durez, Patrick
关节炎
发表日期：2023
文献求助 收藏

Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response

专家意见：培洛替酶联合免疫调节疗法治疗难治性痛风，以提高疗效、安全性和疗效持久性

期刊:Current Rheumatology Reports
影响因子:3.9
doi:10.1007/s11926-022-01055-9
Botson, John K; Baraf, Herbert S B; Keenan, Robert T; Albert, John; Masri, Karim R; Peterson, Jeff; Yung, Christianne; Freyne, Brigid; Amin, Mona; Abdellatif, Abdul; Soloman, Nehad; Edwards, N Lawrence; Strand, Vibeke
代谢
痛风
免疫/内分泌
发表日期：2022
文献求助 收藏